Pharmacodynamic Analysis of Magnetic Resonance Imaging-Monitored Focused Ultrasound-Induced Blood-Brain Barrier Opening for Drug Delivery to Brain Tumors
Figure 9
HE staining. (a) and (b) Small (10-day) tumor tissue without FUS exposure, 40x and 200x. (c) and (d) Small (10-day) tumor tissue with FUS exposure, 40x and 200x. (e) and (f) Large (17-day) tumor tissue without FUS exposure, 40x and 200x. (c) and (d) Large (17-day) tumor tissue with FUS exposure, 40x and 200x.
